Evidence map›Paper›PMID 36343095›Full record

ArticleJournal of neuropathology and experimental neurology2022

Postmortem 7T MRI for guided histopathology and evaluation of cerebrovascular disease.

David Lahna, Natalie Roese, Randy Woltjer, Erin L Boespflug, Daniel Schwartz, John Grinstead, Hiroko H Dodge, Rachel Wall, Jeffrey A Kaye, William D Rooney and 1 more

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Article
  9. Article
  10. Bridging Neuroimaging and Neuropathology: A Comprehensive Workflow for Targeted Sampling of White Matter Lesions.Journal of neuroimaging : official journal of the American Society of Neuroimaging
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David LahnaNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Natalie RoeseNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Randy WoltjerNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Erin L BoespflugNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Daniel SchwartzNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
John GrinsteadSiemens Medical Solutions, Malvern, Pennsylvania, USA.
Hiroko H DodgeNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Rachel WallNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Jeffrey A KayeNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.
William D RooneyAdvanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon, USA.
Lisa C SilbertNIA-Layton Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, Oregon, USA.

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Zachary Beattie · 2020 to 2026
$28.6M
Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WOLTJER, RANDALL L · 1990 to 2019
$27.7M
Ultrastructure and Single Particle Microscopy CoreP30NS061800 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI AICHER, SUE A · 2009 to 2020
$6.6M
White matter hyperintensity-associated astrocytopathy in Alzheimers disease and vascular cognitive impairment A targeted histopathologic study using postmortem 7T MRIR01AG056712 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI SILBERT, LISA C, WOLTJER, RANDALL L · 2018 to 2022
$3.8M
Subcortical Vascular Cognitive Impairment-A Longitudinal Perfusion Imaging StudyR01AG036772 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI SILBERT, LISA C · 2011 to 2015
$1.6M
Characterizing enlarged perivascular spaces in Alzheimer's and vascular dementiaK01AG059842 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BOESPFLUG, ERIN LEIGH · 2018 to 2019
$241k
NIA NIH HHS K01 AG059842NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG066518NIA NIH HHS R01 AG036772NIH HHS R01 AG056712NINDS NIH HHS P30 NS061800VA
6 · The paper itself

Abstract

Postmortem (PM) magnetic resonance imaging (MRI) can serve as a bridge between in vivo imaging and histology by connecting MRI observed macrostructural findings to histological staining and microstructural changes. Data were acquired from 20 formalin-fixed brains including T2, T1, PD, and T2*-weighted images of left hemispheres and 6-mm-thick coronal slices. Tissue slices were bisected, aligned to MR images and used to guide histological sampling. Markers of myelin and oligodendroglia alterations were semiquantitatively rated and compared within white matter hyperintensities (WMHs) and normal-appearing white matter. Tissue priors were created from 3T in vivo data and used to guide segmentation of WMH. PM WMH and hemisphere volumes were compared to volumes derived from in vivo data. PM T2 WMH and T1 hemisphere volumes were correlated with in vivo 3T FLAIR WMH and T1 hemisphere volumes. WMH showed significant myelin loss, decreased GFAP expression and increased vimentin expression. MR-visible perivascular spaces and cortical microvascular lesions were successfully captured on histopathological sections. PM MRI can quantify cerebrovascular disease burden and guide tissue sampling, allowing for more comprehensive characterization of cerebrovascular disease that may be used to study etiologies of age-related cognitive change.

Indexed as

Cerebrovascular DisordersWhite MatterBrainHumansMagnetic Resonance ImagingMyelin Sheath7T MRICerebrovascular diseaseEnlarged perivascular spacesHistologyNeuroimagingPostmortemWhite matter hyperintensity

Identifiers

PMID36343095
PMCPMC9764082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.